Sarcoidosis, Vasculitis and Diffuse Lung Diseases

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

All submissions must meet the following requirements.
- The manuscript has not already been published or submitted for publication elsewhere.
- The manuscript complies with the requirements of the Instructions to Authors in About the Journal.
- In the TITLE box the title of the manuscript is inserted using capital letters only for the first letter of the title and for proper names. In the ABSTRACT box the abstract of the manuscript has been inserted using capital letters only for proper names. In the KEY WORD box at least 3 key words have been inserted using capital letters only for the first letter of each key word and for proper names. In the REFERENCES box, the list of the references of the article.
- Please pay attention to these instructions: the corrections to the articles will be accepted and the articles will be corrected when and only, we will send you the official letter of proofreading request. The submitted corrections not requested by the Editorial Office will not be considered. We will send you the proofreading request about 1 month before the publication of the article.
- With this submission, you agree, in the name and on behalf of any co-authors too, to the use of personal data collected for each purpose connected with this registration, to receive promotional material and, for any other purposes that may be necessary pursuant to EU Reg. N. 679/2016 and of the Legislative Decree n. 101/2018, as well as any other provision on the subject. / Effettuando tale submission, acconsenti, anche in nome e per conto di eventuali coautori, all’utilizzo dei dati personali raccolti per ogni finalità connessa alla presente registrazione, per ricevere materiale promozionale e, per ogni altro scopo che si rendesse necessario ai sensi del Reg. UE n. 679/2016 e del D.lgs. n. 101/2018, nonché di qualsiasi altra disposizione in materia.
- The submission form is filled out with the names and surnames of all authors, and not only of the corresponding author, using capital letters only for the first letter of authors’ names.
- Please, mark in red the Family name of the authors in the Title page file
- Authors are welcome to suggest, in the "Comments for the Editor", at least 2 full names (with their email address and affiliation) of potential Reviewers. The suggested Reviewers must have no conflict of interest with the proposal research. Please, specify the first name and the last name.
- Have you download the two sample files for your online submission?
  SVDLD title page sample and SVDLD manuscript sample. Then, upload both files in your submission.
  
  Make sure that no author information is present in the manuscript file, since we are using double-blind peer review. Please, you should upload the 2 files: "the title page" file and the "manuscript file". As in the samples, the "title page" file must contain: a concise informative title; full author(s) names (full first name and last name); department or institution where work was done (not what you are or you do in this department, as MD, PhD, …); full name and address of author to whom correspondence about the manuscript and request should be referred, as well as fax (if it is available), E-mail and telephone number; a running title of no more than 40 characters. The title page file will not be included in the review process. The manuscript file must contain text, summary, key words, tables and figures, legends, and references.
- Please be sure that the metadata online is correct (when you fill out the form submitting the article). Requests for addition/deletion/change of authors or affiliations received after the publication of the issue will not be considered. The online submission form must contain the full names of all authors, using the button "add contributors" with capital letters only for the first letter of authors’ names. Metadata are crucial for the indexing of the paper and of authors and for attribution of copyright to ALL authors. Attention: Any submission received for a manuscript with more than one contributor, in which only one author has been inserted in the metadata, will result in immediate rejection, asking for a correct re-submission. The author names and affiliations inserted in the online submission system will be those which will be published in PubMed. The Editorial staff is therefore not responsible for eventual inaccuracies or mistakes in the affiliations inserted during the submission process.
- AGREEMENT between MATTIOLI 1885 s.r.l. and the Article’s AUTHOR
  Article 1 Purpose:
  The purpose of this agreement is to ensure effective global dissemination of the Article, enabling the Publisher to carry out necessary activities for publication, distribution, and preservation of the work, respecting the rights of the parties as defined below.
  Article 2 - Rights License:
  By accepting this agreement, the Author grants Mattioli 1885 srl an exclusive license to exploit the rights, as specified below:
  a. Reproduce the Article, in whole or in part, and communicate the Article to the public in print and/or digital form, both individually and in combination with works of others, for example, making it available on the internet or any other networks, as part of a database, online or offline, for third-party use.
  b. Translate the Article into other languages and communicate translations of the Article to the public.
  c. Create adaptations, summaries, or extracts of the Article or other derivative works based on the Article and exercise all rights in such adaptations, summaries, extracts, and derivative works.
  d. The Publisher agrees to acknowledge the Author's name and the source in a standard bibliographic citation.
  Article 3 - Rights Reserved to the Author:
  The Author retains all other rights related to the Article not granted to the Publisher and, in particular, may exercise the following rights, not for profit:
  a. Educational or Research Use: Reproduce the Article, in whole or in part, and communicate or make it available to the public, both in print and/or digital format, as part of an educational package or compilation, for use in educational or research settings within the Author's institution or affiliated institutions.
  b. Preservation: Grant the Author's institution (or another appropriate organization) the authority to preserve the Article to prevent deterioration and ensure the Article continues to be available for educational and research purposes.
  c. Future Reuse: Reuse the whole or part of the Article in a thesis, compilation, or other work.
  d. Personal Use: Present the Article at a meeting or conference.
  Article 4 - Warranties:
  1. The Author guarantees the originality of the work and being its sole creator. The Author also guarantees that the Article does not violate any existing copyright or moral rights of third parties.
  2. The Author guarantees not to have assigned to third parties the right to economic exploitation of the work itself.
  3. The Author will indemnify and compensate the Publisher for any claims from third parties arising from the publication of the Article in case of a breach of this warranty. The warranties in this clause also apply to drawings, tables, photographs, or other illustrations included in the Article and provided by the Author.
  4. The Author guarantees that the content is not defamatory or otherwise injurious to the moral or economic rights of others.
  5. The Author authorizes the Publisher to take, in cooperation with the Author, necessary measures to prevent third-party copyright violations on the Article. The Author and the Publisher agree to provide each other with full cooperation and complete information in this regard. Costs are subject to a separate agreement when the issue arises.
  Article 5 - Publication Obligation:
  Mattioli 1885 undertakes to publish the Article according to customary standards and at the Publisher’s expense within a reasonable period from the acceptance.
  Article 6 - Legal Relationship:
  The Publisher may transfer exploitation rights to a third party, provided that this third party fulfills the Publisher's obligations under this agreement with the Author. If the Author can demonstrate that her/his moral rights are compromised by the Publisher's use of her/his Article, she/he may request the cessation of such use.
  Article 7 - Multiple Authors:
  In the case of multiple Authors, the above-identified Author (first Author) guarantees having the consent of each Author to sign this Publication License on their behalf.
  Article 8 - Final Clause:
  The agreement becomes effective immediately after the Acceptance of the work and remains effective for the entire duration of the copyright on the Article.

INSTRUCTIONS TO AUTHORS

«SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASE» publishes original papers, reviews, short notes and letters on subjects of occupational medicine and industrial hygiene. The contributions should not have been published or submitted to other journals.

The manuscripts, written in English, should be submitted using the journal's website http://www.mattioli1885.com/onlinejournals/index.php/sarcoidosis or www.sarcoidosis.it (to contact the Journal please, email to [email protected]).

The publication in the Journal is free of charge.

Manuscripts are submitted to reviewers and the editorial board reserves the right to suggest alterations or reject any article. Authors will be informed of the reasons for any suggestions or rejections. Opinions expressed by authors are not in any way binding for the Journal.

Please, download and use the two sample files for your online submission: SVDLD title page sample and SVDLD manuscript sample . Then, upload both files in your submission.

MANUSCRIPTS - Manuscripts should be written using Microsoft Word for Windows, 12 font character, double spacing and wide margins. All pages, including references, must be numbered consecutively. The running title should appear at the top of all pages, including references and tables.

FIRST PAGE -The first page of the manuscript should contain the title of the article, the initial and surname of the author or authors, the name in full and surname for female authors, affiliation of each author, indication of any financial support for the research, and complete address of the author responsible for correspondence. On the same page a running title must be provided and at least 3 keywords; the running title must also be repeated at the top of each page of the manuscript.
If the article has already been the subject of a personal communication, a footnote should be added giving the date and place.

TABLES - Tables should be included at the end of the text and should be numbered consecutively with arabic numerals. Each table must be accompanied by a legend. Legends must contain sufficient information to render the table self-explanatory without reference to the text. In the text “tables” must be written in full (e.g. table 1). Tables should be prepared using Microsoft Word for Windows. They should be incorporated in the same file as the text along with legends.

FIGURES – Figures should be numbered consecutively with arabic numerals. Each figure must be accompanied by a legend. In the text, the figure must be cited in full (e.g. Figure 1). The figures can be embedded in the manuscript and should be placed in the right place and not at the end of the article, along with their legends. If Figures are prepared in jpeg or tiff (or high resolution pdf) format, they should be loaded separately as supplementary files. Photographs, drawings, graphs, diagrams must have a minimum size of 10x15 cm. A minimum resolution of 300 dpi is required. Figures will be printed in black and white or on greyscale. Colour figures will be printed in colour only if the authors agree to pay printing costs, but will be visible in the original colour format in the electronic version of the printed article that will be available on the website of the journal. It is the author’s responsibility to ensure that colours printed in greyscale allow a clear reading of the image. If figures or graphs taken from other journals or books are intended to be published, the contributor must obtain prior written authorization to do so from the author and the publisher of such material. A copy of this authorization should be sent to the editorial board of the Journal and the source of the material used should be quoted in the article.

ARRANGEMENT OF MANUSCRIPT - Articles should be divided into Abstract, Introduction, Methods, Results, Discussion, References. Methods should be described in detail only when they are original or substantially modified compared to previous methods. For methods already known and reported in the literature, quotation of the original articles is sufficient. Repetition in the text under Results of data already given in tables and figures should be avoided.

ACCOMPANYING LETTER – In an accompanying letter, the author responsible for correspondence should declare that all the authors have read and agreed with the content and interpretation of the submitted article. The accompanying letter should also contain a declaration signed by the corresponding author also on behalf of all the other authors concerning the existence of any financial agreements that may constitute a potential conflict of interest with the subject matter dealt with in the article.
TITLE: The title must be typed in the space provided in the web site (TITLE).
ABSTRACT: The abstract should describe the study concisely but clearly, highlighting only significant details; it should be divided into: background, objectives, methods, results, conclusions, and should not exceed 250 words. It must be typed in the web site in the space provided (ABSTRACT).
KEY WORDS: In the space provided, at least 3 key words should be inserted using capital letters only for the first letter of each key word and for proper names.

REFERENCES.

Number references, using Arabic numerals in parentheses, in the order in which they first appear in the text. References cited in a table/figure should appear in numeric order relative to the first citation of the table/figure in the text. For example, if the last reference cited before the table/figure in question is mentioned as reference 14, and that table/figure contains 5 references that have not been cited, the references in the table/figure would be numbered 15 through 19. Reference citations in the text would then recommence with number 20.
Appendix material should not have separate reference sections. References that appear in both the text and the appendix should be numbered as they appear in the text. Any references that appear only in the appendix should be added consecutively to the end of the text reference list.
Use the reference style of the National Library of Medicine, including the abbreviations of journal titles.
List all authors when there are 6 or fewer; when there are 7 or more authors, list only the first 3 and add “et al.”.
Do not use ibid. or op cit.
Include an “available from” note for documents that may not be readily accessible.
Cite symposium papers only from published proceedings.
When citing an article or book accepted for publication butnot yet published, include the title of the journal (or name of the publisher) and the year of expected publication.
Include references to unpublished material in the text, not in the references (for example, papers presented orally at a meeting; unpublished work [personal communications, papers in preparation]), and submit a letter of permission from the cited persons to cite such communications (in general, avoid citations to unpublished scientific results).
Ensure that URLs used as references are active and available (the references should include the date on which the author accessed the URL).

FOOTNOTES - Use footnotes only on the title page and in tables. Do not use footnotes in the text. Footnote symbols, in the order in which they should be used, are *, †, ‡, §, ||, ¶, **, ††, ‡‡, and so on. Do not use numbers or letters.

Manuscript categories and requirements for submission

Manuscripts should be typed in 12-point type and double spacing using Times New Roman style.

Original Articles: Main text: 5000 words limit, including the main body of text and abstract, and excluding references, figures and tables. It should carry an abstract of not more than 250-300 words.

Editorials: Editorials should not exceed 2000 words. An abstract is not required, no more than 10 references and 1 figure or table are allowed.

Review articles: Main text: 6000 words max, including an abstract (max. 250-300 words). References: No limit. Figures/Tables: max 10 tables/figures are deemed sufficient.

Case reports: The Case Report article is a detailed description or documentation of an emerging disease, unusual or rare disease, or the unusual manifestation of some common diseases. These contributions could be of up to 2000 words (excluding abstract and references). Abstract (unstructured), Figures/tables (maximum four). Details that might disclose the identity of the subjects under the study should be omitted. In any case, a document enclosing the patient’s agreement to publish all the necessary information must be obtained.

Letters to the Editor: These should be short and concise reports and should be of general interest to the field of medical scientific disciplines and sub-specialities. The letter should not exceed 1200 words, one figure and one table and up to 6 references. Abstract is not required. Key words are not required.

Images in Sarcoidosis: Manuscripts for this section should follow these guidelines: A title of submission that makes it clear what is being reported. Since the submission will be listed on PubMed without an abstract, this will be a key feature to allow others to find these images. Maximum of two figures which demonstrate a characteristic feature (unique or not) of pulmonary or extra-pulmonary sarcoidosis. A text of no more than 750 words. No more than 10 references. For those figures with identifying features, a release from patient for publication.

CLINICAL TRIALS REGISTRATION - All clinical trials must be registered in a public registry prior to submission or the journal won’t consider them.We follow the trials registration policy of the International Committee of Medical Journal Editors (www.ICMJE.org) and consider only trials that have been appropriately registered before submission, regardless of when the trial closed to enrollment. Acceptable registries must meet the following ICMJE requirements: be publicly available, searchable and open to all prospective registrants; have a validation mechanism for registration data; and be managed by a not-for-profit organization.

As defined by the ICMJE, a clinical trial is any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. A medical intervention is any intervention used to modify a health outcome, and includes but is not limited to drugs, surgical procedures, devices, behavioral treatments, and process-of-care changes. A trial must have at least one prospectively assigned concurrent control or comparison group in order to trigger the requirement for registration. Non-randomized trials are not exempt from the registration requirement if they meet the above criteria.

AUTHORSHIP ISSUES - Authorship implies accountability. Listed authors must have contributed directly to the intellectual content of the paper, and the corresponding author should list the specific contributions of all authors in the appropriate section of the Authors’ Form. Authors should meet all of the following criteria, thereby allowing persons named as authors to accept public responsibility for the content of the paper.

Conceived and planned the work that led to the article or played an important role in interpreting the results, or both.
Wrote the paper and/or made substantive suggestions for revision.
Approved the final version.

Holding positions of administrative leadership, contributing patients to a study, and collecting and preparing the data for analysis, however important to the research, are not, by themselves, criteria for authorship. The manuscript should note people who made substantial, direct contributions to the work but did not meet the criteria for authorship in the Acknowledgments section, and should provide a brief description of their contributions.
Medical writers and industry employees can be legitimate contributors, and their roles, affiliations, and potential conflicts of interest should be described when submitting manuscripts. These writers should receive acknowledgment on the byline or in the Acknowledgments section in accord with the degree to which they contributed to the work reported in the manuscript. The Editors consider failure to acknowledge these contributors ghostwriting, and ghostwriting is unacceptable.

CONFLICT ON INTEREST: DEFINITION AND POLICY - The potential for conflict of interest exists when an author (or the author’s institution or employer) has personal or financial relationships that could influence (bias) his or her actions. These relationships vary from those with negligible potential to influence judgment to those with great potential to influence judgment.Not all relationships represent true conflict of interest. Conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment.

Authors must state explicitly whether potential conflicts do or do not exist. Financial relationships (such as employment, consultancies, honoraria, stock ownership or options, paid expert testimony, grants or patents received or pending, and royalties) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and science itself. Authors must disclose all financial relationships (both personal and institutional) that could be viewed as presenting a potential conflict of interest. These include, but are not limited to, any financial relationship that involves conditions or tests or treatments discussed in the manuscript and alternatives to the tests or treatments for those conditions. If authors are uncertain, they should err on the side of full disclosure. Disclosure of these relationships is essential not only for original research articles but also for editorials, letters, commentary, and review articles. Sarcoidosis Vasculitis and Diffuse Lung Diseases will publish conflict of interest disclosures.

AUTHORSHIP: ASSIGNING COPYRIGHT AND DECLARATION PROCESSES - All authors of papers accepted for publication must sign a form transferring copyright of the manuscript to the journal and also affirming that they have met the criteria for authorship, have agreed to be authors, and are aware of the terms of publication. We request that authors complete these forms when we suggest revisions to manuscripts. We do not require them when manuscripts are initially submitted.We also request that authors provide written permission from the individuals that they wish to list in the Acknowledgments section when we suggest revisions to manuscripts.

The corresponding author will serve as the first contact for all communication about manuscripts submitted to Sarcoidosis Vasculitis and Diffuse Lung Diseases, and it is this person’s responsibility to share all Sarcoidosis Vasculitis and Diffuse Lung Diseases communication with all of the authors. In addition, it is the corresponding author’s responsibility to respond to any questions regarding the integrity of the work, including but not limited to requests for study protocols or trial registry information, study data, and documentation of institutional review board approval. If the list of authors changes between submission and final acceptance of an article, it is the corresponding author’s responsibility to explain the changes to the Editors in writing and to obtain written documentation that all of the authors (including deleted authors) approve of the author changes.
All authors, except government employees whose work was done as part of their official duties, must transfer copyright toSarcoidosis Vasculitis and Diffuse Lung Diseases.

COPYRIGHT

© Sarcoidosis Vasculitis and Diffuse Lung Diseases. All rights reserved. Accepted papers become the permanent property of Sarcoidosis Vasculitis and Diffuse Lung Diseases. Transfer of copyright signifies transfer of rights for print publication; electronic publication; production of reprints, facsimiles, microfilm, or microfiche; or publication in a language other than English and no part may be reproduced, stored in a retrieval system or transmitted in any form or by any means without the prior permission of both the author and the publisher.
We usually grant permission on request and without charge when authors ask to use portions of their work published in Sarcoidosis Vasculitis and Diffuse Lung Diseases for limited educational purposes and in other scholarly publications.

GALLEY PROOF

Unless indicated otherwise, galley proofs are sent to the first author and should be returned without delay. Alterations to galley proofs, other than those due to printer’s error, are charged to the author. Accepted and rejected manuscripts are retained for six months after publication or rejection, then destroyed.

ADVERTISEMENTS, BACK ISSUES AND REPRINTS - Advertisers and persons interested in back issues and reprints should contact: Mattioli 1885 - Casa Editrice, Strada di Lodesana 649/sx, Loc. Vaio 43036 Fidenza (Parma), Tel. 0524/530383, Fax 0524/82537, e-mail: [email protected]
«Sarcoidosis Vasculitis and Diffuse Lung Disease» is protected by international copyright law.

Submissions

Submission Preparation Checklist

Author Guidelines

Copyright Notice

Privacy Statement